merck weight loss news - Search News

Merck to develop weight loss pill from Chinese drugmaker

UPI News on MSN · 12h

Merck reaches weight-loss drug deal worth up to $2 billion with China-based Hansoh

Merck announced a weight loss drug deal Wednesday with China-based Hansoh worth up to $2 billion for the pill code-named HS-10535. It includes a $112 million licensing rights payment for global sales outside China.

NBC New York · 19h

Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal

Merck will pay Hansoh $112 million upfront for rights to the drug, with the potential for an additional $1.9 billion in payments and royalties on sales.

Hosted on MSN · 16h

Merck signs up to $2 billion deal for oral weight-loss drug with China's Hansoh

Merck has signed a licensing deal worth up to $2 billion for Chinese biotech Hansoh Pharma's experimental oral drug to treat obesity on Wednesday, becoming a late contender in the race to offer a weight-loss pill to replace weekly shots.

16hon MSN

Merck Licenses a Weight-Loss Pill. It’s Bad News for Obesity Biotechs.

The low-risk approach by the drug giant is a sign of the extent of Eli Lilly and Novo Nordisk’s dominance in the weight-loss ...

11h

Viking Plummets After Merck Inks A $2.01 Billion Obesity Deal — With Someone Else

Merck threw its hat into the obesity race on Wednesday, inking a deal worth up to $2.01 billion with Hansoh Pharma for its ...

Pharmalittle: We’re reading about a Merck deal for an obesity pill, a departing FDA official, and more

Merck signed a deal worth up to $2 billion with Hansoh Pharma to develop and sell the Chinese biotech's oral obesity drug ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results